Why Are People Taking Ozempic? Understanding the Benefits

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, originally developed to treat type 2 diabetes. In recent years, clinical trials have shown that semaglutide can produce significant weight loss—averaging 15% of body weight over 68 weeks in adults without diabetes. Many people are choosing semaglutide as part of a comprehensive weight management strategy.

How Semaglutide Works Inside Your Body

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone your intestines naturally release after eating. When semaglutide activates GLP-1 receptors in your brain, it sends signals that reduce appetite and increase feelings of fullness. This mechanism helps people eat less without requiring constant willpower or restrictive dieting.

Beyond appetite control, semaglutide slows the rate at which food moves through your stomach. This delayed gastric emptying prolongs satiety, meaning you feel satisfied longer after meals. The medication also helps regulate blood sugar levels, which can reduce cravings and energy crashes that often trigger overeating.

Weight Loss Results Patients Experience

Clinical studies demonstrate that patients using semaglutide lose approximately 5–15% of their starting body weight within the first 3–6 months of treatment. Continued use over a year can lead to even greater reductions, with some patients achieving 20% or more weight loss. Results vary based on individual metabolism, genetics, and adherence to a structured nutrition plan.

Weight loss on semaglutide is not sudden but gradual and sustainable. Most patients notice reduced hunger within 2–3 weeks of starting therapy. This steady approach helps preserve muscle mass and allows your body to adapt metabolically, reducing the likelihood of rapid weight regain after stopping the medication.

Metabolic and Health Benefits Beyond the Scale

Semaglutide improves cardiovascular health by reducing blood pressure and triglyceride levels in many patients. Studies show that GLP-1 agonists lower inflammation markers linked to heart disease and stroke risk. For people with obesity and metabolic syndrome, these improvements can be life-changing.

The medication also enhances insulin sensitivity, allowing your cells to use glucose more effectively. This reduces the stress on your pancreas and can lower the risk of developing type 2 diabetes. Additionally, many patients report improved energy levels, better sleep quality, and reduced joint pain as excess weight is lost.

Why PlexusDx Semaglutide Offers Personalized Advantages

PlexusDx compounds semaglutide through licensed 503A compounding pharmacies, ensuring pharmaceutical-grade purity without the supply constraints of branded versions. PlexusDx serves all 50 states with no insurance requirement, making compounded semaglutide accessible at $189 per month—a significant savings for patients seeking prescription-strength GLP-1 therapy.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Who is a good candidate for semaglutide therapy?

Semaglutide is appropriate for adults with a BMI of 27 or higher (or 30+ regardless of comorbidities) who have struggled to lose weight through diet and exercise alone. People with type 2 diabetes, hypertension, or high cholesterol may see additional metabolic benefits. A consultation with a PlexusDx practitioner can determine if semaglutide aligns with your health goals.

How quickly will I see weight loss results?

Most patients notice reduced appetite within 2–3 weeks and measurable weight loss within 4–6 weeks of starting semaglutide. Average weight loss accelerates over 3–6 months as doses are optimized. Individual timelines vary based on genetics, lifestyle, and baseline metabolism.

What does semaglutide cost at PlexusDx?

PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance needed and HSA/FSA eligibility. This flat pricing remains consistent regardless of your dose level—your dose may go up, your price won't. Add the Precision Peptide Genetic Test for $298 to optimize your personalized protocol.

What are the common side effects of semaglutide?

Most side effects are mild and temporary, including nausea, constipation, or mild stomach discomfort, especially during dose increases. These typically resolve within 1–2 weeks as your body adjusts. Serious side effects are rare but can include pancreatitis or thyroid concerns; your PlexusDx practitioner will monitor you throughout treatment.

How does the Precision Peptide Genetic Test improve my results?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (FTO) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.